Stem Cell for In Vitro Modeling of Neurological Disease from thescientistllc on Vimeo.
Stem cells are valuable for neurological disease research and drug development as they permit the in vitro construction of disease models. Human pluripotent stem cells (hPSCs), including human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (ESCs), offer unique advantages for developmental studies. They can be employed in a patient-specific way to identify molecular lesions and aid in therapeutic development. To examine the potential of stem cells for in vitro modeling of neurological disease, The Scientist is bringing together a panel of experts to discuss their research and provide insight into these exciting techniques.
Topics to be covered:
Jaime Imitola, MD, FAAN
Director, Division of Multiple Sclerosis and Translational Neuroimmunology
Vice-Chair of Neurology Research, Department of Neurology
University of Connecticut, School of Medicine
Mark E. Hester, PhD
Principal Investigator, Institute for Genomic Medicine
Abigail Wexner Research Institute, Nationwide Children’s Hospital, Ohio
Assistant Professor, Department of Pediatrics
The Ohio State University College of Medicine
